Cardiac Markers Diagnostic Tests - Medical Devices Pipeline Assessment, 2017

Publisher Name :
Date: 11-Oct-2017
No. of pages: 474

Cardiac Markers Diagnostic Tests - Medical Devices Pipeline Assessment, 2017

Summary

GlobalData's Medical Devices sector report, "Cardiac Markers Diagnostic Tests - Medical Devices Pipeline Assessment, 2017" provides an overview of Cardiac Markers Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiac Markers Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Cardiac Markers Diagnostic Tests under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Cardiac Markers Diagnostic Tests and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry

Reasons to buy

The report enables you to -

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Cardiac Markers Diagnostic Tests under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the product's current stage of development, territory and estimated launch date

Cardiac Markers Diagnostic Tests - Medical Devices Pipeline Assessment, 2017

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 9
1.2 List of Figures 21
2 Introduction 22
2.1 Cardiac Markers Diagnostic Tests Overview 22
3 Products under Development 23
3.1 Cardiac Markers Diagnostic Tests - Pipeline Products by Stage of Development 23
3.2 Cardiac Markers Diagnostic Tests - Pipeline Products by Segment 24
3.3 Cardiac Markers Diagnostic Tests - Pipeline Products by Territory 25
3.4 Cardiac Markers Diagnostic Tests - Pipeline Products by Regulatory Path 26
3.5 Cardiac Markers Diagnostic Tests - Pipeline Products by Estimated Approval Date 27
3.6 Cardiac Markers Diagnostic Tests - Ongoing Clinical Trials 28
4 Cardiac Markers Diagnostic Tests - Pipeline Products under Development by Companies 29
4.1 Cardiac Markers Diagnostic Tests Companies - Pipeline Products by Stage of Development 29
4.2 Cardiac Markers Diagnostic Tests - Pipeline Products by Stage of Development 34
5 Cardiac Markers Diagnostic Tests Companies and Product Overview 42
5.1 1Drop Diagnostics Company Overview 42
5.2 3PrimeDx, Inc. Company Overview 43
5.3 A/C Diagnostics LLC Company Overview 44
5.4 Abbott Diagnostics Company Overview 45
5.5 ACS Biomarker Company Overview 57
5.6 Adaltis S.r.l. Company Overview 58
5.7 AgPlus Diagnostics LTD Company Overview 60
5.8 Akrivis Technologies LLC Company Overview 61
5.9 Alere Inc Company Overview 62
5.10 Alfa Scientific Designs Inc Company Overview 63
5.11 Alfa Wassermann Diagnostic Technologies, LLC Company Overview 64
5.12 Applied Proteomics Inc Company Overview 66
5.13 Arrayit Diagnostics, Inc. Company Overview 68
5.14 Astute Medical Inc Company Overview 69
5.15 Aterovax SA Company Overview 70
5.16 Axela Inc Company Overview 72
5.17 AXO Science SAS Company Overview 73
5.18 Beckman Coulter Inc Company Overview 76
5.19 BG Medicine Inc Company Overview 80
5.20 Biomarker Design Forschungs GmbH Company Overview 81
5.21 bioMerieux S.A. Company Overview 82
5.22 Bio-Rad Laboratories Inc Company Overview 84
5.23 Biouniversa srl Company Overview 85
5.24 Boditech Med Inc Company Overview 86
5.25 British Heart Foundation Company Overview 87
5.26 CardiNor AS Company Overview 88
5.27 Cavadis BV Company Overview 89
5.28 Cellgenex Diagnostics Company Overview 93
5.29 Children's Hospital Boston Company Overview 94
5.30 China Medical Technologies Inc (Inactive) Company Overview 95
5.31 China Sky One Medical Inc Company Overview 101
5.32 Co-Diagnostics HBDC, Inc. Company Overview 102
5.33 CompanDX Ltd. Company Overview 103
5.34 Corgenix Medical Corp Company Overview 104
5.35 Coris BioConcept Company Overview 108
5.36 CPD, LLC Company Overview 109
5.37 Critical Diagnostics Company Overview 110
5.38 DestiNA Genomics Ltd Company Overview 112
5.39 Diagnos Inc Company Overview 113
5.40 Diazyme Laboratories Inc Company Overview 114
5.41 ELITechGroup Inc Company Overview 117
5.42 EMD Millipore Corp Company Overview 120
5.43 Emory University Company Overview 121
5.44 Firalis SAS Company Overview 122
5.45 French National Institute of Health and Medical Research Company Overview 125
5.46 Fujirebio Diagnostics Inc Company Overview 127
5.47 Fundacio Clinic per a la Recerca Biomedica Company Overview 129
5.48 GeneNews Ltd Company Overview 130
5.49 Genesis Detection Systems, Inc. Company Overview 133
5.50 Global Genomics Group LLC Company Overview 135
5.51 Grifols SA Company Overview 138
5.52 Hannover Medical School Company Overview 139
5.53 HealthCheck Diagonstics Inc Company Overview 141
5.54 Infigo Diagnostics Ltd (Inactive) Company Overview 142
5.55 infYnity biomarkers S.A.S. Company Overview 143
5.56 Insilicos LLC Company Overview 144
5.57 iXensor Co. Ltd. Company Overview 145
5.58 John Hopkins University Company Overview 146
5.59 Kamiya Biomedical Company Company Overview 149
5.60 KineMed Inc Company Overview 150
5.61 King's College London Company Overview 151
5.62 Laboratory Corp of America Holdings Company Overview 153
5.63 Magnisense SAS Company Overview 154
5.64 Mayo Clinic US Company Overview 155
5.65 MDNA Life Sciences Inc Company Overview 156
5.66 Medical University of South Carolina Company Overview 157
5.67 Mediomics, LLC Company Overview 159
5.68 MedMira Inc. Company Overview 160
5.69 MetaboGen AB Company Overview 161
5.70 Metanomics Health GmbH Company Overview 162
5.71 Mindray Medical International Ltd Company Overview 164
5.72 MMBiosensing, LLC Company Overview 167
5.73 MyCartis NV Company Overview 168
5.74 MyHealthTest Pty Ltd Company Overview 171
5.75 Nanosphere Inc Company Overview 172
5.76 Nirmidas Biotech Inc Company Overview 174
5.77 NorthShore University Health System Company Overview 175
5.78 Nuclea Biotechnologies Inc. (Inactive) Company Overview 176
5.79 Numares AG Company Overview 177
5.80 Oran Diagnostics LLC Company Overview 178
5.81 Orangelife Company Overview 179
5.82 Oregon Health & Science University Company Overview 183
5.83 Ortho-Clinical Diagnostics Inc Company Overview 184
5.84 Oxford Impedance Diagnostics Ltd Company Overview 187
5.85 Parque Científico de Madrid Company Overview 188
5.86 Prevencio Inc Company Overview 189
5.87 Prognosys LLC Company Overview 191
5.88 Proplex Technologies Llc Company Overview 192
5.89 Proteome Sciences Plc Company Overview 193
5.90 QLIDA Diagnostics Company Overview 194
5.91 Radiometer Medical ApS Company Overview 195
5.92 Randox Laboratories Ltd Company Overview 198
5.93 Rheonix Inc Company Overview 200
5.94 Roche Diagnostics International Ltd Company Overview 201
5.95 ROS Technologies, Inc Company Overview 207
5.96 Rosetta Genomics Ltd Company Overview 208
5.97 Siemens Healthcare GmbH Company Overview 209
5.98 Singulex Inc Company Overview 222
5.99 SomaLogic Inc Company Overview 225
5.100 SpinChip Diagnostics AS Company Overview 227
5.101 SPIROCOR Ltd. Company Overview 229
5.102 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 230
5.103 T2 Biosystems Inc Company Overview 231
5.104 Tcoag Us Inc Company Overview 232
5.105 Tethys Bioscience Inc (Inactive) Company Overview 233
5.106 The Binding Site Group Ltd Company Overview 234
5.107 The Pennsylvania State University Company Overview 236
5.108 The University of Adelaide Company Overview 237
5.109 Thermo Fisher Scientific Inc Company Overview 238
5.110 ThreeFold Sensors (Inactive) Company Overview 240
5.111 TissueNetix Inc Company Overview 241
5.112 Toshiba Medical Systems Corporation Company Overview 242
5.113 Tosoh Bioscience Inc Company Overview 243
5.114 True Diagnostics Inc Company Overview 245
5.115 University College Dublin Company Overview 246
5.116 University Hospital of Lyon Company Overview 247
5.117 University of Arizona Company Overview 248
5.118 University of California San Diego Company Overview 249
5.119 University of California San Francisco Company Overview 250
5.120 University of Colorado Company Overview 251
5.121 University of Illinois Company Overview 252
5.122 University of Montreal Company Overview 253
5.123 University of Nebraska Company Overview 254
5.124 University of Nice Sophia Antipolis Company Overview 255
5.125 University of Oslo Company Overview 256
5.126 University of Otago Company Overview 258
5.127 University of Saskatchewan Company Overview 259
5.128 University of Texas Medical Branch at Galveston Company Overview 260
5.129 University of Texas Southwestern Medical Center Company Overview 261
5.130 University of Tokyo Company Overview 262
5.131 University of Vermont Company Overview 263
5.132 Upstream Medical Technologies Ltd Company Overview 264
5.133 Vaiomer SAS Company Overview 266
5.134 vall d hebron institut de Recerca Company Overview 268
5.135 VEGA Ltd Company Overview 269
5.136 Vermillion Inc Company Overview 270
5.137 Washington University School of Medicine Company Overview 271
6 Cardiac Markers Diagnostic Tests - Recent Developments 272
6.1 Sep 18, 2017: Abbott and the Abbott Fund Expand Support for Hurricane Relief With $1 Million to Help Families Affected by Hurricane Irma 272
6.2 Sep 08, 2017: Singulex Receives New, Broad Patent for Digital Detection Of Cardiac Troponin-I Or Cardiac Troponin-T For Coronary Artery Disease Rule-Out 272
6.3 Sep 07, 2017: Abbott Named Industry Leader for Responsible and Sustainable Business for Five Consecutive Years on the Dow Jones Sustainability Index 273
6.4 Sep 05, 2017: Rosetta Genomics to Reduce Operating and Other Expenses 273
6.5 Aug 30, 2017: bioMerieux - First-Half 2017 Results 274
6.6 Aug 15, 2017: T2 Biosystems and Aridis Pharmaceuticals Join Antimicrobials Working Group 277
6.7 Aug 15, 2017: GeneNews Announces Q2-2017 Financial Results & Provides Progress Update 278
6.8 Aug 10, 2017: Beckman Coulter Diagnostics Announces Enhancements to the Access 2 Immunoassay System 279
6.9 Aug 07, 2017: Luminex Reports Second Quarter 2017 Financial Results 279
6.10 Aug 03, 2017: Siemens extends appointment of CEO Joe Kaeser 280
6.11 Aug 03, 2017: Siemens: Earnings Release Q3 FY 2017 280
6.12 Aug 03, 2017: Alere Reports Second Quarter 2017 Financial Results 282
6.13 Aug 03, 2017: Bio-Rad Reports Second-Quarter 2017 Financial Results 283
6.14 Aug 03, 2017: T2 Biosystems Reports Second Quarter 2017 Financial Results; Provides Company Update 284
6.15 Aug 03, 2017: Diasorin Group Reports Strong Growth in Revenues and Profitability in Q2 2017 285
6.16 Aug 01, 2017: Evaluations of the Analytical Performance of the Singulex Cardiac Troponin I Assay Used on its Single Molecule Counting Technology Platform Demonstrates Ability to Improve Cardiovascular Disease Rule-Out 288
6.17 Aug 01, 2017: Pfizer Reports Second-Quarter 2017 Results 289
6.18 Aug 01, 2017: Proteome Sciences: Directorate changes 293
6.19 Jul 28, 2017: Grifols increases its revenues by 12.3% to EUR 2,192 million driven by growth of its main divisions 294
6.20 Jul 26, 2017: Thermo Fisher Scientific Reports Second Quarter 2017 Results 301
6.21 Jul 25, 2017: Proteome Sciences: Interim Results for the Six Months Ended 30 June 2017 302
6.22 Jul 25, 2017: Quest Diagnostics Reports Second Quarter 2017 Financial Results, Raises 2017 Financial Outlook 303
6.23 Jul 20, 2017: bioMerieux - Second-Quarter 2017 Business Review 303
6.24 Jul 20, 2017: Abbott Reports Second-Quarter 2017 Results 306
6.25 Jul 20, 2017: Trinity Biotech Announces Results for Q2, 2017 308
6.26 Jul 18, 2017: Johnson & Johnson Reports 2017 Second-Quarter Results 309
6.27 Jul 12, 2017: Premaitha Health: Investment Agreement Extension with Thermo Fisher Scientific 311
6.28 Jul 06, 2017: Rosetta Genomics Expands Patent Portfolio in Canada, United States, and China 312
7 Appendix 469
7.1 Methodology 469
7.2 About GlobalData 472
7.3 Contact Us 472
7.4 Disclaimer 472

1.1 List of Tables
Table 1: Cardiac Markers Diagnostic Tests - Pipeline Products by Stage of Development 25
Table 2: Cardiac Markers Diagnostic Tests - Pipeline Products by Segment 26
Table 3: Cardiac Markers Diagnostic Tests - Pipeline Products by Territory 27
Table 4: Cardiac Markers Diagnostic Tests - Pipeline Products by Regulatory Path 28
Table 5: Cardiac Markers Diagnostic Tests - Pipeline Products by Estimated Approval Date 29
Table 6: Cardiac Markers Diagnostic Tests - Ongoing Clinical Trials 30
Table 7: Cardiac Markers Diagnostic Tests Companies - Pipeline Products by Stage of Development 31
Table 8: Cardiac Markers Diagnostic Tests - Pipeline Products by Stage of Development 36
Table 9: 1Drop Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 44
Table 10: One Drop Diagnostic Device - Cardiovascular Disease - Product Status 44
Table 11: One Drop Diagnostic Device - Cardiovascular Disease - Product Description 44
Table 12: 3PrimeDx, Inc. Pipeline Products & Ongoing Clinical Trials Overview 45
Table 13: PulsePredic Test - Product Status 45
Table 14: PulsePredic Test - Product Description 45
Table 15: A/C Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 46
Table 16: Methionine Enzymatic Assay - Product Status 46
Table 17: Methionine Enzymatic Assay - Product Description 46
Table 18: Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 47
Table 19: Alinity ci - Cardiac Diseases - Product Status 48
Table 20: Alinity ci - Cardiac Diseases - Product Description 48
Table 21: ARCHITECT c16000 Integrated System - Galectin-3 Assay - Product Status 48
Table 22: ARCHITECT c16000 Integrated System - Galectin-3 Assay - Product Description 49
Table 23: ARCHITECT c16000 System - High Sensitive Troponin - I Assay - Product Status 49
Table 24: ARCHITECT c16000 System - High Sensitive Troponin - I Assay - Product Description 49
Table 25: ARCHITECT c4000 Integrated System - Galectin-3 Assay - Product Status 50
Table 26: ARCHITECT c4000 Integrated System - Galectin-3 Assay - Product Description 50
Table 27: ARCHITECT c4000 System - High Sensitive Troponin-I Assay - Product Status 50
Table 28: ARCHITECT c4000 System - High Sensitive Troponin-I Assay - Product Description 51
Table 29: ARCHITECT c8000 Integrated System - Galectin-3 Assay - Product Status 51
Table 30: ARCHITECT c8000 Integrated System - Galectin-3 Assay - Product Description 51
Table 31: ARCHITECT c8000 System - High Sensitive Troponin-I Assay - Product Status 52
Table 32: ARCHITECT c8000 System - High Sensitive Troponin-I Assay - Product Description 52
Table 33: ARCHITECT ci16200 Integrated System - High Sensitive Troponin-I Assay - Product Status 52
Table 34: ARCHITECT ci16200 Integrated System - High Sensitive Troponin-I Assay - Product Description 53
Table 35: ARCHITECT ci16200 Integrated System - NT Pro BNP Assay - Product Status 53
Table 36: ARCHITECT ci16200 Integrated System - NT Pro BNP Assay - Product Description 53
Table 37: ARCHITECT ci4100 Integrated System - Galectin-3 Assay - Product Status 53
Table 38: ARCHITECT ci4100 Integrated System - Galectin-3 Assay - Product Description 54
Table 39: ARCHITECT ci4100 Integrated System - High Sensitive Troponin-I Assay - Product Status 54
Table 40: ARCHITECT ci4100 Integrated System - High Sensitive Troponin-I Assay - Product Description 54
Table 41: ARCHITECT ci4100 Integrated System - NT Pro BNP Assay - Product Status 55
Table 42: ARCHITECT ci4100 Integrated System - NT Pro BNP Assay - Product Description 55
Table 43: ARCHITECT ci8200 Integrated System - Galectin-3 Assay - Product Status 55
Table 44: ARCHITECT ci8200 Integrated System - Galectin-3 Assay - Product Description 55
Table 45: ARCHITECT ci8200 Integrated System - High Sensitive Troponin-I Assay - Product Status 56
Table 46: ARCHITECT ci8200 Integrated System - High Sensitive Troponin-I Assay - Product Description 56
Table 47: ARCHITECT i1000SR - NT Pro BNP Assay - Product Status 56
Table 48: ARCHITECT i1000SR - NT Pro BNP Assay - Product Description 57
Table 49: ARCHITECT i1000SR System - High Sensitive Troponin I Assay - Product Status 57
Table 50: ARCHITECT i1000SR System - High Sensitive Troponin I Assay - Product Description 57
Table 51: ARCHITECT i2000SR - NT Pro BNP Assay - Product Status 58
Table 52: ARCHITECT i2000SR - NT Pro BNP Assay - Product Description 58
Table 53: ARCHITECT i4000SR Integrated System - High Sensitive Troponin-I Assay - Product Status 58
Table 54: ARCHITECT i4000SR Integrated System - High Sensitive Troponin-I Assay - Product Description 58
Table 55: ACS Biomarker Pipeline Products & Ongoing Clinical Trials Overview 59
Table 56: Multi-marker Heart Failure Assay - Product Status 59
Table 57: Multi-marker Heart Failure Assay - Product Description 59
Table 58: Adaltis S.r.l. Pipeline Products & Ongoing Clinical Trials Overview 60
Table 59: CLIAgen Cardiac Marker Assay - Product Status 60
Table 60: CLIAgen Cardiac Marker Assay - Product Description 60
Table 61: Diagnostic Assay - hs - CRP - Product Status 61
Table 62: Diagnostic Assay - hs - CRP - Product Description 61
Table 63: AgPlus Diagnostics LTD Pipeline Products & Ongoing Clinical Trials Overview 62
Table 64: AgPlus Diagnostic System - Troponin I Assay - Product Status 62
Table 65: AgPlus Diagnostic System - Troponin I Assay - Product Description 62
Table 66: Akrivis Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 63
Table 67: Z-TECT - cTnI Assay - Product Status 63
Table 68: Z-TECT - cTnI Assay - Product Description 63
Table 69: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview 64
Table 70: Galectin-3 Test - Triage Meter Pro - Product Status 64
Table 71: Galectin-3 Test - Triage Meter Pro - Product Description 64
Table 72: Alfa Scientific Designs Inc Pipeline Products & Ongoing Clinical Trials Overview 65
Table 73: Instant-View Cardiac 3-in-1 Whole Blood/Serum Test - Product Status 65
Table 74: Instant-View Cardiac 3-in-1 Whole Blood/Serum Test - Product Description 65
Table 75: Alfa Wassermann Diagnostic Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 66
Table 76: ACE Axcel System - Apo A1 Assay - Product Status 66
Table 77: ACE Axcel System - Apo A1 Assay - Product Description 66
Table 78: ACE Axcel System - Apo B Assay - Product Status 67
Table 79: ACE Axcel System - Apo B Assay - Product Description 67
Table 80: ACE Axcel System - HsCRP Assay - Product Status 67
Table 81: ACE Axcel System - HsCRP Assay - Product Description 67
Table 82: Applied Proteomics Inc Pipeline Products & Ongoing Clinical Trials Overview 68
Table 83: API Diagnostic Test - Cardiovascular Disease - Product Status 68
Table 84: API Diagnostic Test - Cardiovascular Disease - Product Description 68
Table 85: SimpliPro Cardiac - Product Status 69
Table 86: SimpliPro Cardiac - Product Description 69
Table 87: Arrayit Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 70
Table 88: Companion Diagnostic Test - Plavix - Product Status 70
Table 89: Companion Diagnostic Test - Plavix - Product Description 70
Table 90: Astute Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 71
Table 91: Diagnostic Test - Acute Coronary Syndrome - Product Status 71
Table 92: Diagnostic Test - Acute Coronary Syndrome - Product Description 71
Table 93: Aterovax SA Pipeline Products & Ongoing Clinical Trials Overview 72
Table 94: AteroDx Combo - Product Status 72
Table 95: AteroDx Combo - Product Description 72
Table 96: AteroDx ISO - Product Status 73
Table 97: AteroDx ISO - Product Description 73
Table 98: sPLA2 Atherosclerosis Test - Asymptomatic Patients - Product Status 73
Table 99: sPLA2 Atherosclerosis Test - Asymptomatic Patients - Product Description 73
Table 100: Axela Inc Pipeline Products & Ongoing Clinical Trials Overview 74
Table 101: Cardiac Troponin Biomarker Kit - Product Status 74
Table 102: Cardiac Troponin Biomarker Kit - Product Description 74
Table 103: AXO Science SAS Pipeline Products & Ongoing Clinical Trials Overview 75
Table 104: Multiplexed Detection - BNP - Product Status 75
Table 105: Multiplexed Detection - BNP - Product Description 75
Table 106: Multiplexed Detection - Myoglobin - Product Status 76
Table 107: Multiplexed Detection - Myoglobin - Product Description 76
Table 108: Multiplexed Detection - Troponin - Product Status 76
Table 109: Multiplexed Detection - Troponin - Product Description 77
Table 110: Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 78
Table 111: Access 2 Immunoassay System - hsTnI - Product Status 78
Table 112: Access 2 Immunoassay System - hsTnI - Product Description 78
Table 113: SYNCHRON LXi 725 Anti-Cardiolipin Assay - Product Status 79
Table 114: SYNCHRON LXi 725 Anti-Cardiolipin Assay - Product Description 79
Table 115: SYNCHRON Lxi 725 D-Dimer Assay - Product Status 79
Table 116: SYNCHRON Lxi 725 D-Dimer Assay - Product Description 80
Table 117: SYNCHRON LXi 725 Ischemia Modified Albumin Assay - Product Status 80
Table 118: SYNCHRON LXi 725 Ischemia Modified Albumin Assay - Product Description 80
Table 119: UniCel DxC 600i Synchron Access ß2-Glycoprotein 1 Ab Assay - Product Status 81
Table 120: UniCel DxC 600i Synchron Access ß2-Glycoprotein 1 Ab Assay - Product Description 81
Table 121: BG Medicine Inc Pipeline Products & Ongoing Clinical Trials Overview 82
Table 122: BGM Galectin-3 Test - Adverse Cardiovascular Events - Product Status 82
Table 123: BGM Galectin-3 Test - Adverse Cardiovascular Events - Product Description 82
Table 124: Biomarker Design Forschungs GmbH Pipeline Products & Ongoing Clinical Trials Overview 83
Table 125: Diagnostic Test - Cardiovascular Diseases - Product Status 83
Table 126: Diagnostic Test - Cardiovascular Diseases - Product Description 83
Table 127: bioMerieux S.A. Pipeline Products & Ongoing Clinical Trials Overview 84
Table 128: Magnotech System - Cardiovascular Disease Assay - Product Status 84
Table 129: Magnotech System - Cardiovascular Disease Assay - Product Description 84
Table 130: VIDAS CRP Assay - Product Status 85
Table 131: VIDAS CRP Assay - Product Description 85
Table 132: Bio-Rad Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 86
Table 133: BioPlex 2200 - Cardiac Disease - Product Status 86
Table 134: BioPlex 2200 - Cardiac Disease - Product Description 86
Table 135: Biouniversa srl Pipeline Products & Ongoing Clinical Trials Overview 87
Table 136: BAG3 ELISA - Cardiovascular Disease - Product Status 87
Table 137: BAG3 ELISA - Cardiovascular Disease - Product Description 87
Table 138: Boditech Med Inc Pipeline Products & Ongoing Clinical Trials Overview 88
Table 139: AFIAS-6 Myoglobin Assay - Product Status 88
Table 140: AFIAS-6 Myoglobin Assay - Product Description 88
Table 141: British Heart Foundation Pipeline Products & Ongoing Clinical Trials Overview 89
Table 142: Diagnostic Blood Test - Heart Attack - Product Status 89
Table 143: Diagnostic Blood Test - Heart Attack - Product Description 89
Table 144: CardiNor AS Pipeline Products & Ongoing Clinical Trials Overview 90
Table 145: Secretoneurin Test - Product Status 90
Table 146: Secretoneurin Test - Product Description 90
Table 147: Cavadis BV Pipeline Products & Ongoing Clinical Trials Overview 91
Table 148: CAVARISK CAD - Product Status 91
Table 149: CAVARISK CAD - Product Description 91
Table 150: CAVARISK CVD - Product Status 92
Table 151: CAVARISK CVD - Product Description 92
Table 152: Prognostic Test - Myocardial Infarction - Product Status 92
Table 153: Prognostic Test - Myocardial Infarction - Product Description 93
Table 154: Prognostic Test - Peripheral Artery Disease - Product Status 93
Table 155: Prognostic Test - Peripheral Artery Disease - Product Description 93
Table 156: Prognostic Test - Stroke - Product Status 94
Table 157: Prognostic Test - Stroke - Product Description 94
Table 158: Cellgenex Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 95
Table 159: CardioStent Test - Product Status 95
Table 160: CardioStent Test - Product Description 95
Table 161: Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview 96
Table 162: Biomarker Panel - Cardiac Allograft Vasculopathy - Product Status 96
Table 163: Biomarker Panel - Cardiac Allograft Vasculopathy - Product Description 96
Table 164: China Medical Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 97
Table 165: Cardiac Diseases Reagent Test Kit - ECLIA Analyzer - Product Status 97
Table 166: Cardiac Diseases Reagent Test Kit - ECLIA Analyzer - Product Description 98
Table 167: Diagnostic Assay - C-Reactive Protein - Product Status 98

1.2 List of Figures
Figure 1: Cardiac Markers Diagnostic Tests - Pipeline Products by Stage of Development 25
Figure 2: Cardiac Markers Diagnostic Tests - Pipeline Products by Segment 26
Figure 3: Cardiac Markers Diagnostic Tests - Pipeline Products by Territory 27
Figure 4: Cardiac Markers Diagnostic Tests - Pipeline Products by Regulatory Path 28
Figure 5: Cardiac Markers Diagnostic Tests - Pipeline Products by Estimated Approval Date 29
Figure 6: Cardiac Markers Diagnostic Tests - Ongoing Clinical Trials 30
  • Global Cardiology Point-of-Care (POC) Diagnostics Market Size, Status and Forecast 2022
    Published: 04-Sep-2017        Price: US 3300 Onwards        Pages: 101
    This report studies the global Cardiology Point-of-Care (POC) Diagnostics market, analyzes and researches the Cardiology Point-of-Care (POC) Diagnostics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Siemens - Abbott - Roche - Opko - GE Healthcare - Samsung Health - BioMerieux - Alere - Terumo - Accriva - Akers......
  • Cardiovascular Diagnostic and Monitoring Market 2021: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts for 17 Tests, Technology and Instrumentation Review
    Published: 17-Jul-2017        Price: US 9500 Onwards        Pages: 300
    This new 300-page report from VPGMarketResearch contains 83 tables and provides analysis of the global cardiovascular diagnostic testing and monitoring market, including emerging tests, technologies and instrumentation, volume and sales segment forecasts for 17 tests by country, as well as supplier shares and strategies. During the next five years, the cardiovascular diagnostic and monitoring market will undergo significant transformation.  The market will be driven by convergenc......
  • United States Cardiac POC Testing Devices Market Report 2017
    Published: 16-Jan-2017        Price: US 3800 Onwards        Pages: 102
    Notes: Sales, means the sales volume of Cardiac POC Testing Devices Revenue, means the sales value of Cardiac POC Testing Devices This report studies sales (consumption) of Cardiac POC Testing Devices in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Alere Inc. - Abbott Laboratories - Roche Diagnostics - Beckman Coulter, Inc. - BG Medicine Inc. - Bosto......
  • Global Cardiac POC Testing Devices Market Professional Survey Report 2017
    Published: 13-Jan-2017        Price: US 3500 Onwards        Pages: 127
    Notes: Production, means the output of Cardiac POC Testing Devices Revenue, means the sales value of Cardiac POC Testing Devices This report studies Cardiac POC Testing Devices in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021. This report focuses on top manufacturers in global market, with prod......
  • Global Cardiac POC Testing Devices Sales Market Report 2017
    Published: 11-Jan-2017        Price: US 4000 Onwards        Pages: 101
    Notes: Sales, means the sales volume of Cardiac POC Testing Devices Revenue, means the sales value of Cardiac POC Testing Devices This report studies sales (consumption) of Cardiac POC Testing Devices in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - Alere Inc. - Abbott Laboratories - Ro......
  • Global Cardiac POC Testing Devices Market Research Report 2016
    Published: 27-Dec-2016        Price: US 2900 Onwards        Pages: 101
    Notes: Production, means the output of Cardiac POC Testing Devices Revenue, means the sales value of Cardiac POC Testing Devices This report studies Cardiac POC Testing Devices in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Alere Inc. - Abbott Laboratories - Roche......
  • United States Cardiology Point-of-Care (POC) Diagnostics Market Report 2016
    Published: 01-Nov-2016        Price: US 3800 Onwards        Pages: 105
    Notes: Sales, means the sales volume of Cardiology Point-of-Care (POC) Diagnostics Revenue, means the sales value of Cardiology Point-of-Care (POC) Diagnostics This report studies sales (consumption) of Cardiology Point-of-Care (POC) Diagnostics in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Siemens - Abbott - Roche - Opko - GE Healthcare - Samsung ......
  • Global Cardiology Point-of-Care (POC) Diagnostics Sales Market Report 2016
    Published: 25-Oct-2016        Price: US 4000 Onwards        Pages: 114
    Notes: Sales, means the sales volume of Cardiology Point-of-Care (POC) Diagnostics Revenue, means the sales value of Cardiology Point-of-Care (POC) Diagnostics This report studies sales (consumption) of Cardiology Point-of-Care (POC) Diagnostics in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - Siemens......
  • Global Cardiology Point-of-Care (POC) Diagnostics Market Research Report 2016
    Published: 18-Oct-2016        Price: US 2900 Onwards        Pages: 118
    Notes: Production, means the output of Cardiology Point-of-Care (POC) Diagnostics Revenue, means the sales value of Cardiology Point-of-Care (POC) Diagnostics This report studies Cardiology Point-of-Care (POC) Diagnostics in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering - Siemens - ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs